Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 246Precursor Cell Lymphoblastic Leukemia-Lymphoma 147Myelodysplastic Syndromes 141Leukemia, Lymphocytic, Chronic, B-Cell 140Leukemia 128Lymphoma 80Hematologic Neoplasms 77Lymphoma, Non-Hodgkin 73Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Hodgkin Disease 55Multiple Myeloma 54Myeloproliferative Disorders 37Recurrence 34Lymphoma, Mantle-Cell 29Graft vs Host Disease 28Burkitt Lymphoma 28Lymphoma, B-Cell 26Lymphoma, Follicular 25Leukemia, Biphenotypic, Acute 25Anemia, Refractory, with Excess of Blasts 23Leukemia, Myelomonocytic, Chronic 22Lymphoma, Large B-Cell, Diffuse 21Neoplasms, Plasma Cell 20Lymphoma, B-Cell, Marginal Zone 20Primary Myelofibrosis 19Leukemia, Prolymphocytic 14Leukemia, Myeloid 13Anemia, Aplastic 13Neoplasms 12Leukemia, B-Cell 12

Interventions

AP 1903 reagent 3ON 01910 2Biopsy 2thymoglobulin 1fludarabine phosphate 1fludarabine 1epacadostat 1Specimen Handling 1Sertraline 1Peripheral Blood Stem Cell Transplantation 1Metformin 1IDO-1 inhibitor LY3381916 1Granulocyte Colony-Stimulating Factor 1Genetic Counseling 1Filgrastim 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Bone Marrow Transplantation 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytopenia × fludarabine × Other hematologic neoplasm × Clear all
NCT02143830 2025-11-12

RAFA

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
70 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Fanconi Anemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡